A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation

Suzaki Y., Hamada K., Nomi T., Ito T., Sho M., Kai Y., Nakajima Y., Kimura H.

Source: Eur Respir J 2008; 31: 783-789
Journal Issue: April
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Suzaki Y., Hamada K., Nomi T., Ito T., Sho M., Kai Y., Nakajima Y., Kimura H.. A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation. Eur Respir J 2008; 31: 783-789

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
T-helper cell type-1 transcription factor T-bet is upregulated in pulmonary sarcoidosis
Source: Eur Respir J 2011; 38: 1136-1144
Year: 2011



Allergen challenge increases the number of airway Th2 cells expressing C-C chemokine receptors CCR4 and CCR8
Source: Eur Respir J 2001; 18: Suppl. 33, 529s
Year: 2001

The CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 106s
Year: 2005

CC and C chemokine expression in pulmonary sarcoidosis
Source: Eur Respir J 2002; 20: 1206-1212
Year: 2002



CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge
Source: Eur Respir J 2004; 23: 876-884
Year: 2004



Deletion in macrophage chemokine receptor gene (CCR5) in children with bronchial asthma (BA)
Source: Eur Respir J 2001; 18: Suppl. 33, 450s
Year: 2001

Endobronchial biopsy neutrophilia, IL-8, ENA-78 and neutrophil chemokine receptor (CXCR1 and CXCR2) gene expression in severe exacerbations of asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 588s
Year: 2003

Cytokine modulators as novel therapies for airway disease
Source: Eur Respir J 2001; 18: 67S-77S
Year: 2001



CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis
Source: Eur Respir J 2009; 34: 676
Year: 2009



Idiopathic pulmonary fibrosis fibroblasts migrate and proliferate to CC chemokine ligand 21
Source: Eur Respir J 2007; 29: 1082-1093
Year: 2007



T cell recruitment to the human asthmatic airways is dependent on CC chemokine receptor 4
Source: Eur Respir J 2006; 28: Suppl. 50, 300s
Year: 2006

Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015

Endobronchial biopsy neutrophilia, IL-8, ENA-78 and neutrophil chemokine receptor (CXCR1 & CXCR2) gene expression in severe exacerbations of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 377s
Year: 2002

Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis
Source: Eur Respir J 2003; 21: 925-931
Year: 2003



IL-18 and IL-12 induce inflammatory cytokines, chemokine ligand 9 (CXCL9) and T cell infiltration in pulmonary tissue
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011


The role of chemokine receptors in acute lung allograft rejection
Source: Eur Respir J 2010; 35: 167-175
Year: 2010



Blockade of Th1 chemokine receptors ameliorates pulmonary granulomatosis in mice
Source: Eur Respir J 2011; 38: 415-424
Year: 2011



Enhanced monocyte migration to CXCR3 and CCR5 chemokines in COPD
Source: Eur Respir J 2016; 47: 1093-1102
Year: 2016



Neutrophils and neutrophil chemokine receptor (CXCR1 and 2) gene expression in severe exacerbations of COPD and asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 501s
Year: 2001

IL-33 augments rhinovirus-induced type 2 immune responses in asthma via selective upregulation of one chain of the IL-33 receptor.
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017